Skip to main content
Medical physics

Medical physics

Next-generation plan second check QA and adaptive therapy assessment

13 Jul 2020 Sponsored by MIM Software

Available to watch now, MIM Software explores how MIM SureCalc MonteCarlo can help ensure the highest quality plan for each patient

Want to learn more on this subject?

As the complexity of treatment options continues to increase, it is critical that the plan second check process improves to ensure patient safety.

MIM SureCalc MonteCarlo® provides the means for physicists to administer fully automated, independent 3D Monte Carlo calculation instead of manual point dose checks, improving the scope and accuracy of dose calculation without sacrificing time.

Developed in partnership with Radialogica, MIM SureCalc MonteCarlo provides dose calculation solutions for plan second check and adaptive assessments by utilizing an advanced Monte Carlo algorithm powered by SciMoCa™.

MIM SureCalc MonteCarlo improves multiple areas of the QA workflow to ultimately help physicists ensure that they are delivering the best plan possible for patients. Monte Carlo accuracy for dose calculation and automation is leveraged to provide a single platform that serves multiple purposes and centralizes data.

This webinar will walk through MIM SureCalc MonteCarlo and how it can help ensure the highest quality plan for each patient.

The webinar presented by Neha Dwivedi will talk about:

  • Current realities in pre-treatment and plan second check QA.
  • Catching plan inaccuracies with plan second check.
  • Treatment progress tracking with automated adaptive assessments.

Want to learn more on this subject?

Neha Dwivedi is currently a senior clinical support engineer in the radiation oncology department at MIM Software. She has been with the company for five years. Neha has a BS in biomedical engineering from Case Western Reserve University.

 

 

 

 

Copyright © 2024 by IOP Publishing Ltd and individual contributors